Walgreens #ItEndsWithUs campaign goes to Texas
Walgreens is bringing its #ItEndsWithUs campaign to Dallas to educate local teens about opioid abuse.
Pharmacy
NACDS welcomes Trump ‘Stop Opioid Abuse’ plan
The National Association of Chain Drug Stores applauded President Donald Trump’s new program to combat the drug abuse epidemic, dubbed “Stop Opioids Abuse and Reduce Drug Supply and Demand.
Dr. Reddy’s releases store-brand version of Xyzal Allergy 24HR
Dr. Reddy’s Laboratories has launched levocetirizine dihydrochloride tablets 5 mg, an over-the-counter allergy medication, in the U.S. market. Dr. Reddy’s said its levocetirizine dihydrochloride tablets are a generic version of Xyzal Allergy 24HR Tablets from Chattem-Sanofi. The 5-mg Dr.
CVS Be The First youth anti-smoking drive in 3rd year
As part of its “Be The First” multiyear smoking cessation campaign, CVS Health plans to award $10 million this year to support youth smoking prevention and education programs and strategies nationwide.
Walmart enlists payment tool to spur health incentives
Total health care spending in the U.S. climbed to $3.4 trillion in 2016 and is expected to reach $5.5 trillion by 2020, according to the Centers for Medicare and Medicaid Services.
Senators aim to quash pharmacy gag clauses
A group of senators are sponsoring legislation to bring more prescription drug pricing transparency to the pharmacy counter. Sens. Susan Collins (R., Maine), Claire McCaskill (D., Mo.) and Debbie Stabenow (D., Mich.) yesterday introduced the Patient Right to Know Drug Prices Act (S.
Genoa Healthcare opens doors to 400th pharmacy
Behavioral health pharmacy operator Genoa Healthcare has opened its 400th location in its home state. Tukwila, Wash.-based Genoa on Thursday held the grand opening of its newest pharmacy at Comprehensive Life Resources, a nonprofit behavioral health center in Renton.
Amneal launches two generics
Amneal Pharmaceuticals has launched two generic drugs, including first-to-market erythromycin tablets.
Reese introduces Pinworm Itch Relief Wipes
Reese Pharmaceutical Co. has expanded its product lineup with Reese’s Pinworm Itch Relief Wipes, a new treatment for pinworm itch.
Ex-GSK CEO Andrew Witty to take helm at Optum
Former GlaxoSmithKline plc chief executive officer Sir Andrew Witty has been named CEO of Optum, the health services, technology and pharmacy benefits management unit of health insurance giant UnitedHealth Group. Plans call for Witty to start as Optum CEO on July 1.
IQVIA report sizes up changes in global drug spending
The types of medicines being developed, the way technology contributes to health and how the value of health is calculated are all changing dramatically, according to a new report from the IQVIA Institute for Human Data Science.
CVS Health shareholders OK Aetna acquisition
Shareholders of CVS Health voted overwhelmingly to approve the company’s $69 billion deal to acquire health insurer Aetna Inc.
Cigna to buy Express Scripts for $67 billion
Continuing cross-segment consolidation in the health care arena, health insurer Cigna Corp. plans to acquire pharmacy benefits manager Express Scripts in a $67 billion cash and stock deal.
Perrigo readies store-brand Mucinex DM Maximum Strength
Perrigo Co. has been cleared by the Food and Drug Administration to market over-the-counter guaifenesin and dextromethorphan hydrobromide extended-release tablets 1200 mg/60 mg, an expectorant and cough suppressant.
Walmart health executive George Riedl to depart
George Riedl, senior vice president at Walmart and president of the Walmart Health and Wellness division, is leaving the company. A Walmart spokeswoman said Wednesday that Riedl, a key pharmacy executive at the retail giant, is slated to depart on March 16.
NACDS participates in White House Opioid Summit
The National Association of Chain Drug Stores took part in yesterday’s White House Opioid Summit and continues to give retail pharmacy’s take on how to combat the opioid abuse epidemic.